HOBSCOTCH-CA for Brain Cancer Survivors
This study is testing a home-based program called HOBSCOTCH-CA. It's designed to help people who have survived brain cancer or a brain tumor manage cognitive (thinking and memory) symptoms and improve their quality of life. The program uses problem-solving strategies and coping mechanisms. The study also looks at how HOBSCOTCH-CA might help caregivers of brain cancer patients by reducing their burden and improving their quality of life. You can join if you are 18 or older and have survived brain cancer or a brain tumor. Success will be measured by improvements in your quality of life and how well you feel your thinking abilities are at 3 months after the program.
- Study design
- This study plans to enroll 125 participants. It compares two groups: one receives HOBSCOTCH-CA right away, and the other receives it after a 3-month wait.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your quality of life and cognitive function will be measured at baseline and again 3 months after the intervention.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer)
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Elaine T Kiriakopoulos, MD, MPH, MSc · PRINCIPAL_INVESTIGATOR · Dartmouth-Health/Dartmouth-Hitchcock, Dartmouth College
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Change in quality of life as measured by comparing Neuro-QOL scores at baseline and at 3 months post-intervention in CA Participants.Baseline and 3 months post-intervention
The Neuro-QOL is a self-reported, validated assessment on health-related quality of life covering 17 domains in individuals with neurological disorders. Items are scored on a 5-point Likert scale that uses different language depending on assessment. The questions range from least (1) to most (5) based on frequency of behavior, amount of difficulty, or degree of agreement. Depending on the domain, a higher or lower score can indicate better or poorer quality of life for that domain.
- Change in quality of life as measured by comparing FACT-Br scores at baseline and at 3 months post-intervention in CA Participants.Baseline and 3 months post-intervention
The Functional Assessment of Cancer Therapy-Brain (FACT-Br) is a validated instrument measuring general quality of life (QOL) that reflects symptoms or problems associated with brain malignancies across 5 scales or domains. A 5-point Likert scale from 0 (not at all) to 4 (very much) is utilized with a higher score representing poorer or better QOL depending on the domain.
- Change in subjective cognitive function as measured by comparing scores on the Cognitive Function Sub-Scale (Item Bank 2.0) of the Neuro-QOL at baseline and at 3 months post-intervention in CA Participants.Baseline and 3 months post-intervention
The Cognitive Function sub-scale of the Neuro-QOL is a brief validated tool developed by the NIH for use in patients with neurological disease. Scores range from 8 to 40, with a higher score indicating better reported cognitive functioning.
- Change in CA Participant Caregiver burden as measured by comparing Zarit Burden Interview scores at baseline and at 3 months post-intervention in Caregivers of CA Participants.Baseline and 3 months post-intervention
The Zarit Burden Interview is a 22-item questionnaire designed to measure the extent to which a caregiver perceives his or her level of burden as a result of caring for a person with a particular diagnosis. A 5 point Likert scale is used with a higher score indicating a greater level of perceived burden.